Need help finding what you are looking for?
Contact Us
PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1184454
PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1184454
APAC Spatial Genomics & Transcriptomics Market by Technique(Spatial Transcriptomics(IHC, ISH), Spatial Genomics(FISH, Sequencing)), Product(Instruments, Consumables, Software), Application (Drug Discovery), End User (Biotech, CROs) - Forecast -2027
PUBLISHED:
PAGES: 145 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The Asia Pacific spatial genomics and transcriptomics market is projected to reach USD 152 million by 2027 from USD 64 million in 2022, at a CAGR of 18.9% during the forecast period. The key factors driving the growth of the spatial genomics and transcriptomics market in the Asia Pacific are growing number of consumables for various spatial genomics and transcriptomics applications, introduction of novel products, and increasing adoption of spatial genomics & transcriptomics in drug discovery & development. However, the high capital investments associated with spatial genomics and transcriptomics are expected to restrain market growth to a certain extent.
The Asia Pacific spatial genomics and transcriptomics market has been segmented based on product, technique, application, end user, and country.
"By application, the translational research accounted for the largest share of the Asia Pacific spatial genomics & transcriptomics market"
Based on application, the spatial genomics and transcriptomics market is categorized into translational research and drug discovery & development. The translation research segment dominated the market in 2021, owing to increasing research grants and funding by government and non-government organizations.
"By technique, the spatial transcriptomics accounted for the largest share in the Asia Pacific spatial genomics & transcriptomics market"
Based on technique, the spatial genomics and transcriptomics market is segmented into spatial transcriptomics and spatial genomics analysis. In 2021, the spatial transcriptomics segment accounted for a larger share of the Asia Pacific spatial genomics and transcriptomics market. Growth in this market segment can be attributed to the increasing demand for and high adoption rate of in situ sequencing techniques.
"China: the largest share of the spatial genomics & transcriptomics market"
China accounted for the largest share of the spatial genomics & transcriptomics market. Factors such as rising incidence of chronic diseases, increasing research funding by the government and biopharma companies for the development of new regenerative medicine are the major factors driving the market growth.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side- 60% and Demand Side 40%
- By Designation: Executives - 40%, Research Scientists- 30%, and Managers - 30%
- By Country: Japan- 22%, China- 47%, India- 11%, Rest of APAC- 20%
Prominent Players
- NanoString Technologies, Inc. (US)
- 10X Genomics (US)
- Illumina (US)
- Bio-Rad Laboratories (US)
- Bio-Techne Corporation (US)
- Standard BioTools Inc. (US)
- Genomic Vision SA (France)
- Akoya Biosciences, Inc. (US)
- S2 Genomics (US)
- Cantata Bio (US)
- Vizgen Group (US)
- BGI Group (China)
- Miltenyi Biotec (Germany)
- Bruker (US)
- Perkinelmer Inc. (US)
- Novogene Co., Ltd. (China)
Research Coverage:
This report provides a detailed picture of the spatial genomics & trancriptomics market. It aims at estimating the size and future growth potential of the market across different segments, such as the product, technology, applications, end user, and country. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall spatial genomics & transcriptomics market and its segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.
Product Code: BT 8232
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.2.1 INCLUSIONS AND EXCLUSIONS
- 1.3 STUDY SCOPE
- 1.4 YEARS CONSIDERED
- 1.5 CURRENCY CONSIDERED
- 1.6 LIMITATIONS
- 1.7 STAKEHOLDERS
2 RESEARCH METHODOLOGY
- 2.1 RESEARCH DATA
- FIGURE 1 RESEARCH DESIGN
- 2.1.1 SECONDARY DATA
- 2.1.2 PRIMARY DATA
- FIGURE 2 BREAKDOWN OF PRIMARIES: ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET
- 2.2 MARKET ESTIMATION METHODOLOGY
- FIGURE 3 MARKET SIZE ESTIMATION (COMPANY REVENUE ANALYSIS-BASED ESTIMATION)
- FIGURE 4 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SIZE (USD MILLION)
- FIGURE 5 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: FINAL CAGR PROJECTIONS (2022-2027)
- FIGURE 6 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DEMAND-SIDE DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
- 2.3 MARKET DATA ESTIMATION AND TRIANGULATION
- FIGURE 7 DATA TRIANGULATION METHODOLOGY
- 2.4 INDUSTRY INSIGHTS
- 2.5 RESEARCH ASSUMPTIONS
3 EXECUTIVE SUMMARY
- FIGURE 8 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
- FIGURE 9 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION)
- FIGURE 10 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
- FIGURE 11 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
- FIGURE 12 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SHARE, BY COUNTRY, 2021
4 PREMIUM INSIGHTS
- 4.1 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET OVERVIEW
- FIGURE 13 REDUCED COST OF NEXT-GENERATION SEQUENCING TO DRIVE MARKET GROWTH
- 4.2 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SHARE, BY PRODUCT (2021)
- FIGURE 14 CONSUMABLES SEGMENT DOMINATED MARKET IN JAPAN
- 4.3 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SHARE, BY APPLICATION (2021)
- FIGURE 15 TRANSLATIONAL RESEARCH SEGMENT DOMINATED MARKET IN CHINA
5 MARKET OVERVIEW
- 5.1 INTRODUCTION
- 5.2 MARKET DYNAMICS
- FIGURE 16 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
- TABLE 1 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: IMPACT ANALYSIS
- 5.2.1 DRIVERS
- 5.2.1.1 Reduced cost of next-generation sequencing
- 5.2.1.2 Increasing adoption of spatial genomics and transcriptomics in drug discovery and development
- 5.2.2 RESTRAINTS
- 5.2.2.1 High capital investments
- 5.2.3 OPPORTUNITIES
- 5.2.3.1 Increasing demand for single-cell analysis
- 5.2.4 CHALLENGES
- 5.2.4.1 Analytical limitations associated with spatial techniques
- 5.3 TECHNOLOGY ANALYSIS
- TABLE 2 FIVE BENCHMARK COMPUTATIONAL METHODS: COMPARATIVE ANALYSIS
- 5.4 VALUE CHAIN ANALYSIS
- TABLE 3 INDICATIVE LIST OF DISTRIBUTORS FOR KEY MARKET PLAYERS IN ASIA PACIFIC
- FIGURE 17 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: VALUE CHAIN ANALYSIS
- 5.5 ECOSYSTEM ANALYSIS
- FIGURE 18 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: ECOSYSTEM ANALYSIS
- 5.6 PORTER'S FIVE FORCES ANALYSIS
- TABLE 4 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: PORTER'S FIVE FORCES ANALYSIS
- 5.6.1 THREAT OF NEW ENTRANTS
- 5.6.2 THREAT OF SUBSTITUTES
- 5.6.3 BARGAINING POWER OF BUYERS
- 5.6.4 BARGAINING POWER OF SUPPLIERS
- 5.6.5 INTENSITY OF COMPETITIVE RIVALRY
- 5.7 REGULATORY ANALYSIS
- 5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 5 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.8 PRICING ANALYSIS
- TABLE 6 PRODUCT PRICING: KEY MARKET PLAYERS
- 5.8.1 AVERAGE SELLING PRICE TREND
- 5.9 KEY CONFERENCES AND EVENTS (2020-2023)
- TABLE 7 SPATIAL GENOMICS AND TRANSCRIPTOMICS CONFERENCES (2020-2023)
- 5.10 KEY STAKEHOLDERS AND BUYING CRITERIA
- 5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
- FIGURE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
- 5.10.2 BUYING CRITERIA FOR SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET IN ASIA PACIFIC REGION
- FIGURE 20 KEY BUYING CRITERIA FOR END USERS
6 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT
- 6.1 INTRODUCTION
- TABLE 8 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
- 6.2 CONSUMABLES
- 6.2.1 GROWING USE OF CONSUMABLES FOR VARIOUS SPATIAL GENOMICS AND TRANSCRIPTOMICS APPLICATIONS TO DRIVE GROWTH
- TABLE 9 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
- 6.3 INSTRUMENTS
- 6.3.1 INTRODUCTION OF NOVEL INSTRUMENTS TO DRIVE MARKET
- TABLE 10 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS INSTRUMENTS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
- 6.4 SOFTWARE
- 6.4.1 RISING USE OF SPATIAL OMICS FOR DISEASE DIAGNOSIS TO PROPEL DEMAND FOR SOFTWARE
- TABLE 11 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS SOFTWARE MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
7 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE
- 7.1 INTRODUCTION
- TABLE 12 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
- 7.2 SPATIAL TRANSCRIPTOMICS
- TABLE 13 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
- TABLE 14 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
- 7.2.1 IMMUNOHISTOCHEMISTRY
- 7.2.1.1 Emergence of mIHC/IF to propel growth
- TABLE 15 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
- 7.2.2 IN SITU HYBRIDIZATION
- 7.2.2.1 High adoption of MERFISH to drive growth
- TABLE 16 ASIA PACIFIC: IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
- 7.2.3 SPATIAL TRANSCRIPTOMIC SEQUENCING
- TABLE 17 ASIA PACIFIC: SPATIAL TRANSCRIPTOMIC SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
- 7.2.3.1 Microdissection-based sequencing
- 7.2.3.1.1 Increasing use of microdissection-based sequencing to contribute to market growth
- 7.2.3.1 Microdissection-based sequencing
- TABLE 18 ASIA PACIFIC: MICRODISSECTION-BASED SPATIAL TRANSCRIPTOMIC SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
- 7.2.3.2 In situ sequencing
- 7.2.3.2.1 Increased adoption of in situ sequencing likely to boost market growth
- 7.2.3.2 In situ sequencing
- TABLE 19 ASIA PACIFIC: IN SITU SPATIAL TRANSCRIPTOMIC SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
- 7.2.3.3 Other sequencing technologies
- TABLE 20 ASIA PACIFIC: SPATIAL TRANSCRIPTOMIC SEQUENCING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2020-2027 (USD MILLION)
- 7.2.4 MICROSCOPY-BASED RNA IMAGING
- 7.2.4.1 Increasing use of microscopy-based RNA imaging in cancer research and diagnosis to drive growth
- TABLE 21 ASIA PACIFIC: MICROSCOPY-BASED RNA IMAGING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
- 7.2.5 OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES
- TABLE 22 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2020-2027 (USD MILLION)
- 7.3 SPATIAL GENOMICS ANALYSIS
- TABLE 23 ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
- TABLE 24 ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
- 7.3.1 FLUORESCENCE IN SITU HYBRIDIZATION
- 7.3.1.1 Emerging potential of spatial genomics analysis in cancer diagnostics to support growth
- TABLE 25 ASIA PACIFIC: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
- 7.3.2 SPATIAL GENOMIC SEQUENCING
- 7.3.2.1 Rising adoption of massively parallel sequencing to drive growth
- TABLE 26 ASIA PACIFIC: SPATIAL GENOMIC SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
- 7.3.3 OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES
- TABLE 27 ASIA PACIFIC: OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
8 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION
- 8.1 INTRODUCTION
- TABLE 28 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
- 8.2 TRANSLATIONAL RESEARCH
- 8.2.1 DEMAND FOR SPATIAL TRANSCRIPTOMICS IN UNDERSTANDING TUMOR MICROENVIRONMENT TO DRIVE GROWTH
- TABLE 29 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2020-2027 (USD MILLION)
- 8.3 DRUG DISCOVERY AND DEVELOPMENT
- 8.3.1 RISING USE OF RNA-SEQ IN DRUG DISCOVERY TO DRIVE GROWTH
- TABLE 30 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020-2027 (USD MILLION)
9 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER
- 9.1 INTRODUCTION
- TABLE 31 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
- 9.2 ACADEMIC AND RESEARCH INSTITUTES
- 9.2.1 INCREASING DEMAND FOR SPATIAL GENOMICS AND TRANSCRIPTOMICS IN TRANSLATIONAL RESEARCH TO DRIVE GROWTH
- TABLE 32 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2020-2027 (USD MILLION)
- 9.3 CONTRACT RESEARCH ORGANIZATIONS
- 9.3.1 INCREASING NUMBER OF CROS FORMING STRATEGIC PARTNERSHIPS WITH GENOMICS PROVIDERS TO DRIVE GROWTH
- TABLE 33 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
- 9.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
- 9.4.1 GROWING IMPORTANCE OF BIOMARKERS TO DRIVE DEMAND FOR SPATIAL GENOMICS AND TRANSCRIPTOMICS SYSTEMS
- TABLE 34 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020-2027 (USD MILLION)
10 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY COUNTRY
- 10.1 INTRODUCTION
- TABLE 35 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
- 10.2 CHINA
- 10.2.1 INCREASING R&D SPENDING BY GOVERNMENT AND BIOPHARMA COMPANIES TO SUPPORT MARKET GROWTH
- TABLE 36 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
- TABLE 37 CHINA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
- TABLE 38 CHINA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
- TABLE 39 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
- TABLE 40 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
- TABLE 41 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
- 10.3 JAPAN
- 10.3.1 RISING FUNDING IN JAPAN TO BOOST RESEARCH APPLICATIONS
- TABLE 42 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
- TABLE 43 JAPAN: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
- TABLE 44 JAPAN: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
- TABLE 45 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
- TABLE 46 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
- TABLE 47 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
- 10.4 INDIA
- 10.4.1 COLLABORATIONS BETWEEN HOSPITALS AND DIAGNOSTIC CENTERS FOR LABORATORY SERVICES TO BOOST GROWTH
- TABLE 48 INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
- TABLE 49 INDIA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
- TABLE 50 INDIA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
- TABLE 51 INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
- TABLE 52 INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
- TABLE 53 INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
- 10.4.2 SINGAPORE
- 10.4.2.1 Active partnerships with key players to boost market growth
- TABLE 54 SINGAPORE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
- TABLE 55 SINGAPORE: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
- TABLE 56 SINGAPORE: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
- TABLE 57 SINGAPORE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
- TABLE 58 SINGAPORE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
- TABLE 59 SINGAPORE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
- 10.4.3 SOUTH KOREA
- 10.4.3.1 Government initiatives and strong R&D expenditure to propel demand for spatial solutions
- TABLE 60 SOUTH KOREA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
- TABLE 61 SOUTH KOREA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
- TABLE 62 SOUTH KOREA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
- TABLE 63 SOUTH KOREA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
- TABLE 64 SOUTH KOREA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
- TABLE 65 SOUTH KOREA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
- 10.4.4 AUSTRALIA
- 10.4.4.1 Increasing adoption of spatial solutions by research institutions to propel growth
- TABLE 66 AUSTRALIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
- TABLE 67 AUSTRALIA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
- TABLE 68 AUSTRALIA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
- TABLE 69 AUSTRALIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
- TABLE 70 AUSTRALIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
- TABLE 71 AUSTRALIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
- 10.4.5 REST OF ASIA PACIFIC
- TABLE 72 REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
- TABLE 73 REST OF ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
- TABLE 74 REST OF ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
- TABLE 75 REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
- TABLE 76 REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
- TABLE 77 REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2027 (USD MILLION)
11 COMPETITIVE LANDSCAPE
- 11.1 INTRODUCTION
- 11.2 RIGHT-TO-WIN STRATEGIES ADOPTED BY KEY PLAYERS
- FIGURE 21 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
- 11.3 REVENUE SHARE ANALYSIS (TOP SIX PLAYERS)
- 11.4 MARKET SHARE ANALYSIS (2021)
- 11.5 COMPANY EVALUATION MATRIX
- 11.5.1 STARS
- 11.5.2 EMERGING LEADERS
- 11.5.3 PERVASIVE PLAYERS
- 11.5.4 PARTICIPANTS
- FIGURE 24 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: COMPANY EVALUATION MATRIX (2021)
- 11.6 COMPETITIVE SCENARIO AND TRENDS
- 11.6.1 DEALS
- TABLE 78 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: DEALS
- 11.6.1.1 Product launches
- TABLE 79 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: PRODUCT LAUNCHES
- 11.6.1.2 Other developments
- TABLE 80 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: OTHER DEVELOPMENTS
12 COMPANY PROFILES
- 12.1 KEY PLAYERS
- (Business Overview, Products, Recent Developments, MnM View)**
- 12.1.1 NANOSTRING
- TABLE 81 NANOSTRING: BUSINESS OVERVIEW
- FIGURE 25 NANOSTRING: COMPANY SNAPSHOT (2021)
- 12.1.2 10X GENOMICS
- TABLE 82 10X GENOMICS: BUSINESS OVERVIEW
- FIGURE 26 10X GENOMICS: COMPANY SNAPSHOT (2021)
- 12.1.3 ILLUMINA
- TABLE 83 ILLUMINA: BUSINESS OVERVIEW
- FIGURE 27 ILLUMINA: COMPANY SNAPSHOT (2021)
- 12.1.4 BIO-RAD LABORATORIES, INC.
- TABLE 84 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
- FIGURE 28 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021)
- 12.1.5 BIO-TECHNE
- TABLE 85 BIO-TECHNE: BUSINESS OVERVIEW
- FIGURE 29 BIO-TECHNE: COMPANY SNAPSHOT (2021)
- 12.1.6 STANDARD BIOTOOLS
- TABLE 86 STANDARD BIOTOOLS: BUSINESS OVERVIEW
- FIGURE 30 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2021)
- 12.1.7 AKOYA BIOSCIENCES
- TABLE 87 AKOYA BIOSCIENCES: BUSINESS OVERVIEW
- FIGURE 31 AKOYA BIOSCIENCES: COMPANY SNAPSHOT (2021)
- 12.1.8 S2 GENOMICS
- TABLE 88 S2 GENOMICS: BUSINESS OVERVIEW
- 12.1.9 CANTATA BIO
- TABLE 89 CANTATA BIO: BUSINESS OVERVIEW
- 12.1.10 VIZGEN CORP.
- TABLE 90 VIZGEN: BUSINESS OVERVIEW
- *Details on Business Overview, Products, Recent Developments, MnM View might not be captured in case of unlisted companies.
- 12.2 OTHER PLAYERS
- 12.2.1 BGI GROUP
- 12.2.2 MILTENYI BIOTEC
- 12.2.3 BRUKER
- 12.2.4 PERKINELMER INC.
- 12.2.5 NOVOGENE CO., LTD.
13 APPENDIX
- 13.1 DISCUSSION GUIDE
- 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 13.3 CUSTOMIZATION OPTIONS
- 13.4 RELATED REPORTS
- 13.5 AUTHOR DETAILS
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.